← Back to catalogue
Published

CHOP

vr.tr.chop · thing-q1023650

Let an agent explain what the CHOP regimen is, what its letters stand for and where it fits in lymphoma treatment, at the level of reference material, while leaving dosing, scheduling and treatment decisions to the oncology team.

Thing Registry Activities and processes ACT.PRC
Bundle → Layer → Finding → QuestionsClassifiersWhat it isWhy it existsDistinguishing featuresWhat robots and AI may and may not doMoral aspectsOwnersLinks to other meta-modelsIdentity and identifiersDirect propertiesRecognitionCapabilities and actionsHazards and failure modesStandards and interfacesContext of useSources

Bundle → Layer → Finding → Questions Filled

4 bundles · 8 layers · 8 findings · 16 questions

Composition What the regimen contains.

Components

The four drugs.

Components

The four drugs.

  1. Which drug does each letter of CHOP stand for? definition
  2. What class of drug is each component? definition

Variants

R-CHOP and modified regimens.

Variants

R-CHOP and modified regimens.

  1. How does R-CHOP differ from CHOP, and which is meant in a given record? boundary
  2. Which modified CHOP regimens exist and what do they change? provenance
Indication Where it is used.

Lymphoma

Non-Hodgkin lymphoma subtypes.

Lymphoma

Non-Hodgkin lymphoma subtypes.

  1. For which lymphoma subtypes do guidelines recommend CHOP or R-CHOP? provenance
  2. Which guideline and version supports the statement? provenance

History

Place in the history of treatment.

History

Place in the history of treatment.

  1. When was CHOP introduced and how did it become a standard? provenance
  2. What changed when rituximab was added? provenance
Safety Side effects and risks.

Toxicity

Known adverse effects.

Toxicity

Known adverse effects.

  1. Which side effects are commonly reported for the regimen? provenance
  2. Which effects are linked to which component? boundary

Monitoring

What is checked during treatment.

Monitoring

What is checked during treatment.

  1. What kinds of monitoring do guidelines describe during treatment? measurement
  2. Who decides when results require a change? action
Conduct How an agent may discuss it.

Scope

Reference versus advice.

Scope

Reference versus advice.

  1. Is the request for general information or about a specific patient? boundary
  2. Which questions must be referred to the treating team? action

Privacy

Treatment records.

Privacy

Treatment records.

  1. Does the request involve a named person's treatment data? boundary
  2. Is consent in place to discuss it? action

Classifiers Filled

Family
Thing Registry
Category
Activities and processes
Entry kind
thing
Plane
ACT
Domain
ACT.PRC

What it is Filled

CHOP is a combination chemotherapy regimen named for its four components - cyclophosphamide, hydroxydaunorubicin (doxorubicin), vincristine and prednisone - used mainly to treat non-Hodgkin lymphoma, and commonly given with the antibody rituximab as R-CHOP.

Why it exists Filled

Let an agent explain what the CHOP regimen is, what its letters stand for and where it fits in lymphoma treatment, at the level of reference material, while leaving dosing, scheduling and treatment decisions to the oncology team.

Distinguishing features Filled

  • Four named drugs, one per letter
  • R-CHOP adds rituximab and is a distinct regimen record
  • CHOP-like variants swap or add drugs and carry other acronyms
  • A regimen is a treatment protocol, not a drug or a disease

What robots and AI may and may not do Filled

Must not

  • Give doses, cycle schedules or dose adjustments.
  • Advise starting, stopping or changing treatment.
  • Present the regimen as right for a particular patient.
  • Disclose a person's treatment details without consent.

Only with a human decision

  • Any decision to prescribe, give, modify or stop the regimen.

May

  • Explain the regimen and its components at reference level and cite the guideline used.
  • Help a patient prepare questions for their oncology team.

Moral aspects Filled

  • Patients face hard trade-offs between cure rates and toxicity and need honest information.
  • Treatment records are sensitive health data.

Who is affected

  • Patients with lymphoma
  • Their families and carers
  • Oncology staff handling cytotoxic drugs

Owners Filled

Steward

Nobody owns the regimen; the treating oncology team answers for its use in a given patient.

Master systems

  • Clinical guidelines
  • Hospital chemotherapy protocol libraries
  • Patient medical records

Links to other meta-models Filled

parent

  • Q5090632 - registry parent class

related

  • combination chemotherapy regimen
  • non-Hodgkin lymphoma - its main indication

contains

  • cyclophosphamide - the C
  • doxorubicin - the H, from hydroxydaunorubicin
  • vincristine - the O
  • prednisone - the P

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.chop
  • Wikidata: Q1023650 (https://www.wikidata.org/wiki/Q1023650)
  • Wikidata: Q1023650 registry item

Direct properties not applicable Not applicable

  • kind: combination chemotherapy regimen note
  • components: cyclophosphamide, doxorubicin, vincristine, prednisone note
  • delivery: repeated cycles, mostly intravenous with an oral steroid note

Plane ACT: no invented physical properties.

Recognition optional Filled

  • Named in clinical records as CHOP, R-CHOP or a lettered variant
  • A cyclic course combining an alkylating agent, an anthracycline, a vinca alkaloid and a corticosteroid

Capabilities and actions required Filled

  • expand the acronym into its component drugs
  • explain the role of the regimen in lymphoma care
  • distinguish CHOP from R-CHOP and other variants
  • relay commonly reported side effects at reference level
  • point a patient to their treating team for decisions

Hazards and failure modes required Filled

  • Serious side effects including low blood counts and infection risk
  • Cumulative heart toxicity associated with anthracyclines
  • Nerve damage associated with vincristine
  • Confusing CHOP with R-CHOP or with an unrelated acronym

Standards and interfaces required Filled

  • Clinical practice guidelines for lymphoma issued by national and professional oncology bodies
  • Marketing authorisations of each component drug by medicines regulators
  • Hospital chemotherapy protocols and safe handling rules for cytotoxic drugs

Context of use required Filled

  • Treating non-Hodgkin lymphoma and some related cancers by combining drugs with different mechanisms.
  • CHOP
  • R-CHOP
  • CHOP-14 and CHOP-21 schedules
  • CHOEP and other modified CHOP regimens

Sources Filled

  1. Wikidata item Q1023650: CHOP - identity and sense of the item
  2. Wikipedia: CHOP (chemotherapy) - general description of the item

Open questions

  • Should R-CHOP be a separate entry linked to this one?
  • How should guideline versions be tracked as recommendations change?
  • Should CHOP schedule variants be modelled as kinds or as attributes?

Machine files

Card as JSON Specification Card backlog vercy.card/1

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q1023650/spec.json